151 related articles for article (PubMed ID: 8555065)
1. Involvement of the cyclin-dependent kinase-4 inhibitor (CDKN2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukaemia.
Serra A; Gottardi E; Della Ragione F; Saglio G; Iolascon A
Br J Haematol; 1995 Nov; 91(3):625-9. PubMed ID: 8555065
[TBL] [Abstract][Full Text] [Related]
2. Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia.
Sill H; Goldman JM; Cross NC
Blood; 1995 Apr; 85(8):2013-6. PubMed ID: 7718873
[TBL] [Abstract][Full Text] [Related]
3. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.
Nakai H; Misawa S; Toguchida J; Yandell DW; Ishizaki K
Cancer Res; 1992 Dec; 52(23):6588-93. PubMed ID: 1423304
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between blast crisis of chronic myeloid leukemias and abnormality of p16 and calcitonin genes].
Xu D; Hong W; Wang S
Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):151-3. PubMed ID: 11776646
[TBL] [Abstract][Full Text] [Related]
5. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques.
Neubauer A; He M; Schmidt CA; Huhn D; Liu ET
Leukemia; 1993 Apr; 7(4):593-600. PubMed ID: 8464238
[TBL] [Abstract][Full Text] [Related]
7. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
8. Changing p53 mutations with the evolution of chronic myeloid leukaemia from the chronic phase to blast crisis.
Guinn BA; Smith M; Padua RA; Burnett A; Mills K
Leuk Res; 1995 Aug; 19(8):519-25. PubMed ID: 7658697
[TBL] [Abstract][Full Text] [Related]
9. Genetic analysis of p53 and RB1 tumor-suppressor genes in blast crisis of chronic myeloid leukemia.
Gaidano G; Serra A; Guerrasio A; Rege-Cambrin G; Mazza U; Saglio G
Ann Hematol; 1994 Jan; 68(1):3-7. PubMed ID: 8110876
[TBL] [Abstract][Full Text] [Related]
10. Genomic p16 abnormalities in the progression of chronic myeloid leukemia into blast crisis: a sequential study in 42 patients.
Hernández-Boluda JC; Cervantes F; Colomer D; Vela MC; Costa D; Paz MF; Esteller M; Montserrat E
Exp Hematol; 2003 Mar; 31(3):204-10. PubMed ID: 12644017
[TBL] [Abstract][Full Text] [Related]
11. Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisis.
Foti A; Ahuja HG; Allen SL; Koduru P; Schuster MW; Schulman P; Bar-Eli M; Cline MJ
Blood; 1991 Jun; 77(11):2441-4. PubMed ID: 2039825
[TBL] [Abstract][Full Text] [Related]
12. P53 tumor suppressor gene in chronic myelogenous leukemia: a sequential study.
Rovira A; Urbano-Ispizua A; Cervantes F; Rozman M; Vives-Corrons JL; Montserrat E; Rozman C
Ann Hematol; 1995 Mar; 70(3):129-33. PubMed ID: 7718641
[TBL] [Abstract][Full Text] [Related]
13. No evidence for microsatellite instability or consistent loss of heterozygosity at selected loci in chronic myeloid leukaemia blast crisis.
Silly H; Chase A; Mills KI; Apfelbeck U; Sormann S; Goldman JM; Cross NC
Leukemia; 1994 Nov; 8(11):1923-8. PubMed ID: 7967738
[TBL] [Abstract][Full Text] [Related]
14. The role of alternative splicing patterns of BCR/ABL transcripts in the generation of the blast crisis of chronic myeloid leukaemia.
Morgan GJ; Hernandez A; Chan LC; Hughes T; Martiat P; Wiedemann LM
Br J Haematol; 1990 Sep; 76(1):33-8. PubMed ID: 2223646
[TBL] [Abstract][Full Text] [Related]
15. Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia.
Manachai N; Saito Y; Nakahata S; Bahirvani AG; Osato M; Morishita K
Biochem Biophys Res Commun; 2017 Jan; 482(4):994-1000. PubMed ID: 27908728
[TBL] [Abstract][Full Text] [Related]
16. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma.
Ohta M; Berd D; Shimizu M; Nagai H; Cotticelli M-G ; Mastrangelo M; Shields JA; Shields CL; Croce CM; Huebner K
Int J Cancer; 1996 Mar; 65(6):762-7. PubMed ID: 8631588
[TBL] [Abstract][Full Text] [Related]
17. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
18. Biphenotypic blast crisis of chronic myelogenous leukemia: abnormalities of p53 and retinoblastoma genes.
Ishikura H; Yufu Y; Yamashita S; Abe Y; Okamura T; Motomura S; Nishimura J; Nawata H
Leuk Lymphoma; 1997 May; 25(5-6):573-8. PubMed ID: 9250829
[TBL] [Abstract][Full Text] [Related]
19. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia.
Watzinger F; Gaiger A; Karlic H; Becher R; Pillwein K; Lion T
Cancer Res; 1994 Jul; 54(14):3934-8. PubMed ID: 8033117
[TBL] [Abstract][Full Text] [Related]
20. CDKN2 gene deletion is not found in chronic lymphoid leukaemias of B- and T-cell origin but is frequent in acute lymphoblastic leukaemia.
Schröder M; Mathieu U; Dreyling MH; Bohlander SK; Hagemeijer A; Beverloo BH; Olopade OI; Stilgenbauer S; Fischer K; Bentz M
Br J Haematol; 1995 Dec; 91(4):865-70. PubMed ID: 8547131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
